Iscaffpharma is a Bio-Tech company that focuses on developing better treatments for aggressive cancers. It provides a cost-effective platform to improve the success rate in clinical development of treatments for aggressive cancer. The company is based on research by Professor Göran Landberg and Associate Professor Anders Ståhlberg at Sahlgrenska Cancer Center.
Iscaffpharma’s website does not have any products listed, nor does it have any pricing information. However, it does mention that it is developing synthetic 3D-models to improve cancer drug development with 3D printed scaffolds.